(+)-lariciresinol increases expression ISO RGD:1346853 6480464 lariciresinol results in increased expression of UBC protein CTD PMID:27417256 (-)-lariciresinol increases expression ISO RGD:1346853 6480464 lariciresinol results in increased expression of UBC protein CTD PMID:27417256 (1->4)-beta-D-glucan multiple interactions ISO RGD:1624057 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of UBC mRNA CTD PMID:36331819 (S)-nicotine multiple interactions ISO RGD:1624057 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1,2-dimethylhydrazine multiple interactions ISO RGD:1624057 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of UBC mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:1624057 6480464 1, 2-Dimethylhydrazine results in increased expression of UBC mRNA CTD PMID:22206623 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression ISO RGD:1624057 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO RGD:1624057 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 17alpha-ethynylestradiol multiple interactions ISO RGD:1624057 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBC mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1624057 6480464 Ethinyl Estradiol results in increased expression of UBC mRNA CTD PMID:17555576 , PMID:17942748 17beta-estradiol increases expression ISO RGD:1346853 6480464 Estradiol results in increased expression of UBC mRNA CTD PMID:20106945 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1624057 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1624057 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBC mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of UBC mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1624057 6480464 Tetrachlorodibenzodioxin affects the expression of UBC mRNA CTD PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of UBC mRNA CTD PMID:16466705 , PMID:18465118 2,4,6-trinitrobenzenesulfonic acid increases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in increased expression of UBC mRNA CTD PMID:12163651 2-butoxyethanol increases expression ISO RGD:1624057 6480464 n-butoxyethanol results in increased expression of UBC mRNA CTD PMID:19812364 2-methylcholine affects expression ISO RGD:1346853 6480464 beta-methylcholine affects the expression of UBC mRNA CTD PMID:21179406 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1624057 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of UBC mRNA CTD PMID:18648102 5-(hydroxymethyl)cytosine multiple interactions ISO RGD:1346853 6480464 [Chloranil results in increased abundance of 5-hydroxymethylcytosine] which results in increased expression of UBC mRNA CTD PMID:24214992 acetamide increases expression EXP 6480464 acetamide results in increased expression of UBC mRNA CTD PMID:31881176 acrylamide increases expression ISO RGD:1346853 6480464 Acrylamide results in increased expression of UBC mRNA CTD PMID:32763439 aflatoxin B1 decreases methylation ISO RGD:1346853 6480464 Aflatoxin B1 results in decreased methylation of UBC gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:1346853 6480464 Tretinoin results in increased expression of UBC mRNA CTD PMID:33167477 all-trans-retinol increases expression EXP 6480464 Vitamin A deficiency results in increased expression of UBC mRNA CTD PMID:12163651 alpha-hexachlorocyclohexane increases expression EXP 6480464 alpha-hexachlorocyclohexane results in increased expression of UBC mRNA CTD PMID:16940010 aminoglutethimide increases expression ISO RGD:1346853 6480464 Aminoglutethimide results in increased expression of UBC protein CTD PMID:26102013 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of UBC mRNA CTD PMID:16483693 aristolochic acid A increases expression ISO RGD:1346853 6480464 aristolochic acid I results in increased expression of UBC mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:1346853 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of UBC mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1346853 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of UBC mRNA CTD PMID:32525701 arsenite(3-) increases response to substance ISO RGD:1624057 6480464 UBC gene mutant form results in increased susceptibility to arsenite CTD PMID:25701757 arsenous acid decreases expression ISO RGD:1346853 6480464 Arsenic Trioxide results in decreased expression of UBC protein CTD PMID:19364129 Azaspiracid increases expression ISO RGD:1346853 6480464 azaspiracid results in increased expression of UBC mRNA CTD PMID:28939011 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UBC mRNA CTD PMID:33854195 benzatropine increases expression ISO RGD:1346853 6480464 Benztropine results in increased expression of UBC protein CTD PMID:34122009 benzo[a]pyrene increases expression ISO RGD:1624057 6480464 Benzo(a)pyrene results in increased expression of UBC mRNA CTD PMID:19770486 more ... beta-naphthoflavone increases expression ISO RGD:1346853 6480464 beta-Naphthoflavone results in increased expression of UBC mRNA CTD PMID:19737606 bisphenol A decreases expression ISO RGD:1624057 6480464 bisphenol A results in decreased expression of UBC mRNA CTD PMID:23798566 bisphenol A increases expression ISO RGD:1624057 6480464 bisphenol A results in increased expression of UBC mRNA CTD PMID:32156529 , PMID:33221593 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of UBC mRNA CTD PMID:30903817 bisphenol A affects expression ISO RGD:1346853 6480464 bisphenol A affects the expression of UBC mRNA CTD PMID:30903817 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of UBC mRNA CTD PMID:30816183 , PMID:34947998 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of UBC mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of UBC mRNA CTD PMID:26496021 butane-2,3-dione increases expression EXP 6480464 Diacetyl results in increased expression of UBC protein CTD PMID:34031698 cadmium atom decreases expression ISO RGD:1624057 6480464 Cadmium results in decreased expression of UBC CTD PMID:29415948 cadmium dichloride multiple interactions ISO RGD:1624057 6480464 [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of UBC mRNA CTD PMID:19840844 cadmium dichloride increases expression ISO RGD:1346853 6480464 Cadmium Chloride results in increased expression of UBC mRNA CTD PMID:26558471 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of UBC mRNA CTD PMID:19010381 , PMID:33453195 cadmium sulfate increases expression ISO RGD:1346853 6480464 cadmium sulfate results in increased expression of UBC mRNA CTD PMID:21783983 cadmium sulfate multiple interactions ISO RGD:1624057 6480464 cadmium sulfate affects the reaction [MTF1 affects the expression of UBC mRNA] CTD PMID:16221973 caffeine multiple interactions ISO RGD:1624057 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 cannabidiol multiple interactions ISO RGD:1346853 6480464 [Cannabidiol co-treated with moringin] results in increased expression of UBC mRNA CTD PMID:30096889 cannabidiol decreases expression ISO RGD:1346853 6480464 Cannabidiol results in decreased expression of UBC mRNA CTD PMID:31801206 cannabidiol increases expression ISO RGD:1624057 6480464 Cannabidiol results in increased expression of UBC mRNA CTD PMID:31052254 carbon nanotube decreases expression ISO RGD:1624057 6480464 Nanotubes, Carbon results in decreased expression of UBC mRNA CTD PMID:25620056 chlordecone increases expression ISO RGD:1624057 6480464 Chlordecone results in increased expression of UBC mRNA CTD PMID:33711761 chloropicrin decreases expression ISO RGD:1346853 6480464 chloropicrin results in decreased expression of UBC mRNA CTD PMID:26352163 chloroquine increases expression EXP 6480464 Chloroquine results in increased expression of UBC mRNA CTD PMID:19296457 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of UBC mRNA CTD PMID:18668222 chlorpyrifos increases expression ISO RGD:1624057 6480464 Chlorpyrifos results in increased expression of UBC mRNA CTD PMID:29156651 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UBC mRNA CTD PMID:33854195 chromium(3+) trichloride multiple interactions EXP 6480464 chromic chloride promotes the reaction [INS1 protein results in decreased expression of UBC mRNA] CTD PMID:20013160 chromium(3+) trichloride decreases expression EXP 6480464 chromic chloride results in decreased expression of UBC mRNA CTD PMID:20013160 ciguatoxin CTX1B affects expression ISO RGD:1624057 6480464 Ciguatoxins affects the expression of UBC mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:1624057 6480464 Cisplatin results in increased expression of UBC mRNA CTD PMID:32738330 clofibrate decreases expression ISO RGD:1624057 6480464 Clofibrate results in decreased expression of UBC mRNA CTD PMID:17585979 clofibrate multiple interactions ISO RGD:1624057 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of UBC mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of UBC mRNA] CTD PMID:17585979 cobalt dichloride increases expression ISO RGD:1346853 6480464 cobaltous chloride results in increased expression of UBC mRNA CTD PMID:17553155 more ... copper(II) chloride increases expression ISO RGD:1346853 6480464 cupric chloride results in increased expression of UBC mRNA CTD PMID:17211630 copper(II) sulfate increases expression ISO RGD:1346853 6480464 Copper Sulfate results in increased expression of UBC mRNA CTD PMID:19549813 crotonaldehyde increases expression ISO RGD:1346853 6480464 2-butenal results in increased expression of UBC mRNA CTD PMID:20471460 Cuprizon multiple interactions ISO RGD:1346853 6480464 [Cuprizone co-treated with Haloperidol] results in increased expression of UBC protein CTD PMID:34122009 curcumin increases expression ISO RGD:1346853 6480464 Curcumin results in increased expression of UBC mRNA CTD PMID:16101141 cyclosporin A increases expression ISO RGD:1346853 6480464 Cyclosporine results in increased expression of UBC mRNA CTD PMID:20106945 cyclosporin A increases methylation ISO RGD:1346853 6480464 Cyclosporine results in increased methylation of UBC promoter CTD PMID:27989131 decabromodiphenyl ether increases expression ISO RGD:1624057 6480464 decabromobiphenyl ether results in increased expression of UBC mRNA CTD PMID:29699156 dexamethasone increases expression ISO RGD:1624057 6480464 Dexamethasone results in increased expression of UBC mRNA CTD PMID:21041162 diarsenic trioxide decreases expression ISO RGD:1346853 6480464 Arsenic Trioxide results in decreased expression of UBC protein CTD PMID:19364129 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of UBC mRNA CTD PMID:17379624 dichloroacetic acid increases expression ISO RGD:1624057 6480464 Dichloroacetic Acid results in increased expression of UBC mRNA CTD PMID:28962523 diclofenac affects expression ISO RGD:1624057 6480464 Diclofenac affects the expression of UBC mRNA CTD PMID:26934552 diethylstilbestrol increases expression ISO RGD:1624057 6480464 Diethylstilbestrol results in increased expression of UBC mRNA CTD PMID:21041162 dinophysistoxin 1 increases expression ISO RGD:1346853 6480464 dinophysistoxin 1 results in increased expression of UBC mRNA CTD PMID:28939011 doxorubicin increases expression ISO RGD:1624057 6480464 Doxorubicin results in increased expression of UBC mRNA CTD PMID:22016648 enzalutamide affects expression ISO RGD:1346853 6480464 enzalutamide affects the expression of UBC mRNA CTD PMID:30940724 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of UBC mRNA CTD PMID:18035473 fluoranthene multiple interactions ISO RGD:1624057 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of UBC mRNA CTD PMID:28329830 flusilazole affects expression ISO RGD:1624057 6480464 flusilazole affects the expression of UBC mRNA CTD PMID:21195148 flutamide increases expression EXP 6480464 Flutamide results in increased expression of UBC mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:1624057 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of UBC mRNA] CTD PMID:22206623 furan decreases expression EXP 6480464 furan results in decreased expression of UBC mRNA CTD PMID:26194646 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UBC mRNA CTD PMID:33854195 graphene oxide decreases expression ISO RGD:1624057 6480464 graphene oxide results in decreased expression of UBC mRNA CTD PMID:33227293 haloperidol multiple interactions ISO RGD:1346853 6480464 [Cuprizone co-treated with Haloperidol] results in increased expression of UBC protein CTD PMID:34122009 hexaconazole affects expression ISO RGD:1624057 6480464 hexaconazole affects the expression of UBC mRNA CTD PMID:21195148 hydrogen cyanide increases expression ISO RGD:1624057 6480464 Hydrogen Cyanide results in increased expression of UBC mRNA CTD PMID:33914522 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of UBC protein CTD PMID:31969611 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UBC mRNA CTD PMID:33854195 imidazopyrazole increases expression ISO RGD:1346853 6480464 imidazopyrazole analog results in increased expression of UBC mRNA CTD PMID:30388846 isoprenaline decreases expression ISO RGD:1624057 6480464 Isoproterenol results in decreased expression of UBC mRNA CTD PMID:20003209 lead diacetate decreases expression ISO RGD:1624057 6480464 lead acetate results in decreased expression of UBC mRNA CTD PMID:21829687 leflunomide decreases expression ISO RGD:1346853 6480464 leflunomide results in decreased expression of UBC mRNA CTD PMID:28988120 Licochalcone B increases expression ISO RGD:1346853 6480464 licochalcone B results in increased expression of UBC mRNA CTD PMID:33647349 lipopolysaccharide multiple interactions ISO RGD:1346853 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of UBC mRNA CTD PMID:35877022 maneb multiple interactions ISO RGD:1624057 6480464 [Paraquat co-treated with Maneb] results in increased expression of UBC mRNA CTD PMID:18386188 menadione affects expression ISO RGD:1346853 6480464 Vitamin K 3 affects the expression of UBC mRNA CTD PMID:20044591 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of UBC mRNA CTD PMID:24042092 methylisothiazolinone increases expression ISO RGD:1346853 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of UBC mRNA CTD PMID:31629900 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:1624057 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of UBC mRNA CTD PMID:30186748 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:1346853 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of UBC mRNA CTD PMID:30186748 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1346853 6480464 HSF1 promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of UBC mRNA] CTD PMID:30186748 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO RGD:1624057 6480464 [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of UBC mRNA more ... CTD PMID:19840844 N-nitrosodiethylamine increases expression ISO RGD:1624057 6480464 Diethylnitrosamine results in increased expression of UBC mRNA CTD PMID:17942915 N-nitrosodiethylamine multiple interactions ISO RGD:1624057 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of UBC mRNA] CTD PMID:17942915 nickel subsulfide increases expression ISO RGD:1346853 6480464 nickel subsulfide results in increased expression of UBC mRNA CTD PMID:12760830 nicotine multiple interactions ISO RGD:1624057 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 nitric oxide increases expression ISO RGD:1624057 6480464 Nitric Oxide deficiency results in increased expression of UBC mRNA CTD PMID:15878706 okadaic acid multiple interactions ISO RGD:1624057 6480464 [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of UBC mRNA CTD PMID:19840844 oxidopamine increases expression EXP 6480464 Oxidopamine results in increased expression of UBC mRNA CTD PMID:12486162 paracetamol increases expression ISO RGD:1624057 6480464 Acetaminophen results in increased expression of UBC mRNA, Acetaminophen results in increased expression of UBC protein CTD PMID:11264010 , PMID:21329376 paracetamol multiple interactions ISO RGD:1624057 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of UBC mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of UBC mRNA] CTD PMID:17585979 paracetamol affects expression ISO RGD:1624057 6480464 Acetaminophen affects the expression of UBC mRNA CTD PMID:15606129 paraquat increases expression ISO RGD:1624057 6480464 Paraquat results in increased expression of UBC mRNA CTD PMID:12595580 paraquat multiple interactions ISO RGD:1624057 6480464 [Paraquat co-treated with Maneb] results in increased expression of UBC mRNA CTD PMID:18386188 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1624057 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of UBC mRNA CTD PMID:36331819 phenobarbital affects expression ISO RGD:1624057 6480464 Phenobarbital affects the expression of UBC mRNA CTD PMID:23091169 phlorizin decreases expression ISO RGD:1624057 6480464 Phlorhizin results in decreased expression of UBC mRNA CTD PMID:22538082 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1624057 6480464 [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of UBC mRNA CTD PMID:19840844 picolinic acid multiple interactions EXP 6480464 picolinic acid promotes the reaction [INS1 protein results in decreased expression of UBC mRNA] CTD PMID:20013160 picolinic acid decreases expression EXP 6480464 picolinic acid results in decreased expression of UBC mRNA CTD PMID:20013160 potassium cyanide decreases expression ISO RGD:1624057 6480464 Potassium Cyanide results in decreased expression of UBC mRNA CTD PMID:33914522 pyrogallol increases expression ISO RGD:1624057 6480464 Pyrogallol results in increased expression of UBC mRNA CTD PMID:20362636 quercetin decreases expression ISO RGD:1624057 6480464 Quercetin results in decreased expression of UBC mRNA CTD PMID:19496084 resveratrol multiple interactions ISO RGD:1624057 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of UBC mRNA] CTD PMID:31298478 rotenone increases expression EXP 6480464 Rotenone results in increased expression of UBC protein CTD PMID:31969611 S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression ISO RGD:1624057 6480464 Buthionine Sulfoximine results in increased expression of UBC mRNA CTD PMID:15878706 silicon dioxide increases expression ISO RGD:1624057 6480464 Silicon Dioxide results in increased expression of UBC mRNA CTD PMID:19073995 , PMID:33720480 silver atom increases expression ISO RGD:1346853 6480464 Silver results in increased expression of UBC mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:1346853 6480464 Silver results in increased expression of UBC mRNA CTD PMID:26014281 sodium arsenate multiple interactions ISO RGD:1346853 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of UBC mRNA CTD PMID:32525701 sodium arsenite increases expression ISO RGD:1346853 6480464 sodium arsenite results in increased expression of UBC mRNA CTD PMID:12760830 more ... sodium arsenite increases expression ISO RGD:1624057 6480464 sodium arsenite results in increased expression of UBC mRNA CTD PMID:30186748 sodium arsenite multiple interactions ISO RGD:1346853 6480464 HSF1 promotes the reaction [sodium arsenite results in increased expression of UBC mRNA] more ... CTD PMID:30186748 sodium arsenite decreases response to substance ISO RGD:1624057 6480464 UBC mRNA results in decreased susceptibility to sodium arsenite CTD PMID:28237703 sodium arsenite multiple interactions ISO RGD:1624057 6480464 UBC mRNA promotes the reaction [sodium arsenite results in increased expression of PSMA1 mRNA] CTD PMID:28237703 sodium arsenite increases stability ISO RGD:1346853 6480464 sodium arsenite results in increased stability of UBC mRNA CTD PMID:25493608 sodium dichromate increases expression ISO RGD:1346853 6480464 sodium bichromate results in increased expression of UBC mRNA CTD PMID:12760830 sulfasalazine increases expression ISO RGD:1624057 6480464 Sulfasalazine results in increased expression of UBC mRNA CTD PMID:22016648 tamoxifen affects expression ISO RGD:1624057 6480464 Tamoxifen affects the expression of UBC mRNA CTD PMID:17555576 , PMID:20937368 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of UBC mRNA CTD PMID:26496021 tetrachloro-1,4-benzoquinone multiple interactions ISO RGD:1346853 6480464 [Chloranil results in increased abundance of 5-hydroxymethylcytosine] which results in increased expression of UBC mRNA CTD PMID:24214992 tetrachloro-1,4-benzoquinone increases expression ISO RGD:1346853 6480464 Chloranil results in increased expression of UBC mRNA CTD PMID:24214992 tetrachloroethene decreases expression ISO RGD:1624057 6480464 Tetrachloroethylene results in decreased expression of UBC mRNA CTD PMID:28973375 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of UBC mRNA CTD PMID:15963342 tetrachloromethane increases expression ISO RGD:1624057 6480464 Carbon Tetrachloride results in increased expression of UBC mRNA CTD PMID:31919559 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UBC mRNA CTD PMID:33854195 titanium dioxide increases expression ISO RGD:1624057 6480464 titanium dioxide results in increased expression of UBC mRNA CTD PMID:31298478 titanium dioxide multiple interactions ISO RGD:1624057 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of UBC mRNA] CTD PMID:31298478 toluene affects expression EXP 6480464 Toluene affects the expression of UBC mRNA CTD PMID:21827849 triadimefon affects expression ISO RGD:1624057 6480464 triadimefon affects the expression of UBC mRNA CTD PMID:21195148 tungsten decreases expression ISO RGD:1624057 6480464 Tungsten results in decreased expression of UBC mRNA CTD PMID:30912803 urethane increases expression ISO RGD:1346853 6480464 Urethane results in increased expression of UBC mRNA CTD PMID:28818685 valproic acid decreases methylation ISO RGD:1346853 6480464 Valproic Acid results in decreased methylation of UBC gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1624057 6480464 Valproic Acid affects the expression of UBC mRNA CTD PMID:17292431 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of UBC mRNA CTD PMID:23034163 vincristine decreases expression ISO RGD:1346853 6480464 Vincristine results in decreased expression of UBC mRNA CTD PMID:23649840 zinc atom multiple interactions ISO RGD:1346853 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of UBC mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1346853 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of UBC mRNA CTD PMID:18593933
